All the pieces are falling into place.
If anyone thinks that SI and the team have not been in heavy talks with major players - well they're kidding themselves.
The prep work needed is huge and we can rest assured it is happening.
This award is just one more piece, and a very nice one at that, in this very long journey.
I believe FDA approval is the next one we need - before an early halt to the C-19 trial. It just works better for MSB that way.
IMO, MSB is the best bio play on the market today - by a country mile.
Here we go ... fingers and toes crossed
Ann: MSB Wins Fierce Biotech Innovation Award for Remestemcel-L, page-197
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.41 |
Change
0.620(34.6%) |
Mkt cap ! $3.084B | |||
| Open | High | Low | Value | Volume |
| $1.90 | $2.48 | $1.90 | $58.82M | 25.68M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 100915 | $2.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.41 | 99 | 1 |
View Market Depth
| Last trade - 16.12pm 18/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |